×

BioCorRx, Inc. Announces Availability of its Start Fresh Program for Treating Addiction in Oklahoma City, Oklahoma

Los Angeles, Dec. 4, 2014 (GLOBE NEWSWIRE) -- BioCorRx, Inc. (BICX), developer of the Start Fresh Program®, announces expansion into Oklahoma with the opening of a Start Fresh Recovery clinic in Oklahoma City, Oklahoma. The new clinic will be owned and operated by multiple wholly owned subsidiaries of Start Fresh Midwest Holdings, LLC, which consist of common majority owners of Fresh Start Private Midwest, LLC who purchased the territory in a transaction completed in June 2014. The group currently operates a Start Fresh clinic in Nebraska. "We are pleased that the Start Fresh Program is expanding into a new state through a group who has experience with our program," states COO and interim CEO Brady Granier. The clinic is located at 5015 N Pennsylvania Avenue, Oklahoma City, OK 73112 and is scheduling free consultations now for appointments starting December 10th.

The population of Oklahoma is nearly 4 million people, with around 600,000 residing in Oklahoma City alone. The city is also within a short driving distance to many parts of Texas including Dallas, which boasts a population of approximately 1.2 million people. According to the Centers for Disease Control, Oklahoma ranks as one of the highest states for prescription drug overdose deaths in the nation. Drunk-driving fatalities have steadily increased in the state over the last decade, the highest concentration of which occur in Oklahoma County where Oklahoma City is located. Bringing the Start Fresh Program to this new area will positively impact many families while creating a broader revenue stream for BioCorRx, Inc. With the opening of this clinic, there will now be 10 locations across the United States using the Start Fresh Program.

"The Start Fresh Program will be highly beneficial to families and individuals suffering from addiction in Oklahoma and its surrounding areas. The Start Fresh Program brings these families and individuals access to the tools that have helped many others in getting on the road to recovery," says Granier. "This group has had success at their other clinic location and we are pleased for the opportunity to continue to work with them as they expand in their territories."

Visit BioCorRx, Inc.'s new investor relations website www.BICXcorp.com to receive the most up to date company information.

Click here to view Recent National Television Media on the BioCorRx YouTube Channel

Click here for company Facebook page for more stories and media coverage

About BioCorRx ®, Inc.

BioCorRx, Inc. (OTCQB: BICX) is an addiction treatment and rehabilitation company on the leading edge of substance abuse addiction treatment. The company has developed a highly effective program called the Start Fresh Program® consisting of two components used by various addiction clinics in the US. Clinic reports show that the treatment program has an extremely high success rate with individuals that complete the program. The first component of the program consists of an outpatient implant procedure performed by a licensed physician that delivers therapeutic levels of the drug Naltrexone, an opioid antagonist that significantly reduces physical cravings for alcohol and opioids, into the body. The second component of the program developed by BioCorRx, Inc. is a one on one coaching program specifically tailored for the treatment of alcoholism and other substance abuse addictions. BioCorRx® and Start Fresh Program® are registered trademarks of BioCorRx, Inc. For more information on BICX, visit www.BioCorRx.com

Safe Harbor Statement

The information in this release includes forward-looking statements. These forward-looking statements generally are identified by the words "believe," "project," "estimate," "become," "plan," "will," and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this release. Although the Company believes that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof.

CONTACT: Investor Relations SmallCapVoice.com, Inc. 512-267-2430

Source:BioCorRx